| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $223.2M | +101.4% |
| Cost of Revenue | $133.6M | +120.9% |
| R&D Expense | $154.5M | +27.5% |
| SG&A Expense | $70.5M | +46.1% |
| Operating Income | -$135.4M | -13.7% |
| Interest Expense | $8.7M | +411.2% |
| Pre-tax Income | -$133.4M | -147.8% |
| Income Tax | -$4.5M | -338.1% |
| Net Income | -$117.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $151.7M | -52.8% |
| Accounts Receivable | $63.6M | +140.5% |
| Inventory | $33.1M | +150.0% |
| Current Assets | $271.8M | -27.3% |
| Total Assets | $818.9M | +35.7% |
| Current Liabilities | $138.9M | +117.1% |
| Long-term Debt | $156.7M | +0.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$104.4M | -36.0% |
| Capital Expenditures | $12.8M | +68.5% |
| Investing Cash Flow | -$107.7M | -562.1% |
| Financing Cash Flow | $43.6M | -77.4% |
| Free Cash Flow | -$117.1M | -38.9% |
| -171.0% |
| EPS (Basic) | -$0.81 | -118.9% |
| EPS (Diluted) | -$0.81 | -118.9% |
| Total Liabilities |
| $341.9M |
| +18.3% |
| Stockholders' Equity | $446.1M | +42.6% |